Article Versions Notes

Battah B, Chemi G, Butini S, Campiani G, Brogi S, Delogu G, Gemma S. A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles. Molecules. 2019; 24(23):4373. https://doi.org/10.3390/molecules24234373

Battah, Basem, Giulia Chemi, Stefania Butini, Giuseppe Campiani, Simone Brogi, Giovanni Delogu, and Sandra Gemma. 2019. "A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles" Molecules 24, no. 23: 4373. https://doi.org/10.3390/molecules24234373

Battah, B., Chemi, G., Butini, S., Campiani, G., Brogi, S., Delogu, G., & Gemma, S. (2019). A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles. Molecules, 24(23), 4373. https://doi.org/10.3390/molecules24234373